Turnstone Biologics Corp. Common Stock (TSBX) — Net Asset Quality Index
Turnstone Biologics Corp. Common Stock (TSBX) has a Net Asset Quality Index of 69.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $21.11 Million minus total liabilities of $6.34 Million yields net assets of $14.76 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check cash flow quality index of Turnstone Biologics Corp. Common Stock to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Turnstone Biologics Corp. Common Stock Net Asset Quality Index Over Time (2021–2024)
This chart shows how Turnstone Biologics Corp. Common Stock's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the index stands at 69.9%, representing net assets of $14.76 Million against total assets of $21.11 Million USD. See TSBX net assets for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Turnstone Biologics Corp. Common Stock (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for Turnstone Biologics Corp. Common Stock from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see TSBX stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 78.4% | $31.47 Million | $40.14 Million | $8.67 Million | ▼ -9.1 pp |
| 2023 | 87.5% | $98.67 Million | $112.81 Million | $14.15 Million | ▲ +175.7 pp |
| 2022 | -88.3% | $-101.47 Million | $114.94 Million | $216.41 Million | ▼ -44.6 pp |
| 2021 | -43.7% | $-81.85 Million | $187.24 Million | $269.10 Million | — |